News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
747,290 Results
Type
Article (48739)
Company Profile (331)
Press Release (698204)
Multimedia
Podcasts (106)
Webinars (19)
Section
Business (210494)
Career Advice (2421)
Deals (36238)
Drug Delivery (129)
Drug Development (82922)
Employer Resources (197)
FDA (16673)
Job Trends (15404)
News (355264)
Policy (33662)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2783)
Academic (2)
Accelerated approval (31)
Adcomms (27)
Allergies (139)
Alliances (51484)
ALS (172)
Alzheimer's disease (1715)
Antibody-drug conjugate (ADC) (315)
Approvals (16922)
Artificial intelligence (541)
Autoimmune disease (146)
Automation (38)
Bankruptcy (367)
Best Places to Work (11868)
BIOSECURE Act (21)
Biosimilars (189)
Biotechnology (204)
Bladder cancer (159)
Brain cancer (55)
Breast cancer (642)
Cancer (4825)
Cardiovascular disease (403)
Career advice (2045)
Career pathing (39)
CAR-T (289)
CDC (51)
Celiac Disease (2)
Cell therapy (764)
Cervical cancer (37)
Clinical research (70401)
Collaboration (1740)
Company closure (4)
Compensation (1141)
Complete response letters (56)
COVID-19 (2805)
CRISPR (93)
C-suite (846)
Cystic fibrosis (144)
Data (6196)
Decentralized trials (2)
Denatured (40)
Depression (135)
Diabetes (499)
Diagnostics (6845)
Digital health (44)
Diversity (13)
Diversity, equity & inclusion (48)
Drug discovery (258)
Drug pricing (199)
Drug shortages (29)
Duchenne muscular dystrophy (229)
Earnings (91084)
Editorial (59)
Employer branding (25)
Employer resources (167)
Events (121208)
Executive appointments (991)
FDA (19787)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (23)
Funding (1500)
Gene editing (203)
Generative AI (47)
Gene therapy (611)
GLP-1 (1016)
Government (4855)
Grass and pollen (6)
Guidances (384)
Healthcare (19343)
HIV (58)
Huntington's disease (47)
IgA nephropathy (83)
Immunology and inflammation (253)
Immuno-oncology (54)
Indications (103)
Infectious disease (3069)
Inflammatory bowel disease (193)
Inflation Reduction Act (16)
Influenza (111)
Intellectual property (247)
Interviews (399)
IPO (16896)
IRA (51)
Job creations (3875)
Job search strategy (1709)
JPM (59)
Kidney cancer (15)
Labor market (91)
Layoffs (579)
Leadership (35)
Legal (8164)
Liver cancer (92)
Longevity (15)
Lung cancer (650)
Lymphoma (374)
Machine learning (43)
Management (63)
Manufacturing (804)
MASH (164)
Medical device (13971)
Medtech (14025)
Mergers & acquisitions (20404)
Metabolic disorders (1285)
Multiple sclerosis (157)
NASH (22)
Neurodegenerative disease (322)
Neuropsychiatric disorders (89)
Neuroscience (2959)
Neurotech (1)
NextGen: Class of 2026 (6778)
Non-profit (4705)
Now hiring (66)
Obesity (613)
Opinion (287)
Ovarian cancer (166)
Pain (203)
Pancreatic cancer (225)
Parkinson's disease (289)
Partnered (35)
Patents (494)
Patient recruitment (474)
Peanut (57)
People (61020)
Pharmaceutical (73)
Pharmacy benefit managers (29)
Phase 1 (21966)
Phase 2 (30965)
Phase 3 (23066)
Pipeline (5117)
Policy (297)
Postmarket research (2651)
Preclinical (9567)
Press Release (72)
Prostate cancer (236)
Psychedelics (50)
Radiopharmaceuticals (283)
Rare diseases (837)
Real estate (6305)
Recruiting (77)
Regulatory (25032)
Reports (64)
Research institute (2566)
Resumes & cover letters (420)
Rett syndrome (27)
RNA editing (17)
RSV (78)
Schizophrenia (152)
Series A (250)
Series B (190)
Service/supplier (13)
Sickle cell disease (100)
Special edition (23)
Spinal muscular atrophy (160)
Sponsored (43)
Startups (3830)
State (2)
Stomach cancer (18)
Supply chain (107)
Tariffs (89)
The Weekly (64)
Vaccines (1032)
Venture capital (90)
Weight loss (399)
Women's health (89)
Worklife (21)
Date
Today (6)
Last 7 days (608)
Last 30 days (2249)
Last 365 days (30422)
2026 (2887)
2025 (30820)
2024 (36027)
2023 (40973)
2022 (52043)
2021 (56661)
2020 (55120)
2019 (47876)
2018 (36124)
2017 (33239)
2016 (32854)
2015 (38946)
2014 (32564)
2013 (27699)
2012 (29963)
2011 (30743)
2010 (29214)
Location
Africa (835)
Alabama (85)
Alaska (7)
Arizona (315)
Arkansas (14)
Asia (41164)
Australia (6798)
California (11277)
Canada (3277)
China (1101)
Colorado (481)
Connecticut (474)
Delaware (335)
Europe (90203)
Florida (1668)
Georgia (367)
Hawaii (4)
Idaho (62)
Illinois (870)
India (64)
Indiana (525)
Iowa (23)
Japan (424)
Kansas (127)
Kentucky (40)
Louisiana (27)
Maine (72)
Maryland (1389)
Massachusetts (8151)
Michigan (340)
Minnesota (647)
Mississippi (6)
Missouri (127)
Montana (31)
Nebraska (28)
Nevada (123)
New Hampshire (80)
New Jersey (3019)
New Mexico (30)
New York (2986)
North Carolina (1492)
North Dakota (10)
Northern California (5481)
Ohio (334)
Oklahoma (21)
Oregon (42)
Pennsylvania (2269)
Puerto Rico (22)
Rhode Island (47)
South America (1202)
South Carolina (65)
South Dakota (1)
Southern California (4384)
Tennessee (174)
Texas (1756)
United States (40234)
Utah (339)
Vermont (1)
Virginia (261)
Washington D.C. (86)
Washington State (939)
West Virginia (4)
Wisconsin (122)
Wyoming (2)
747,290 Results for "applied sciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
CHINA SXT PHARMACEUTICALS, INC. ANNOUNCES STRATEGIC INITIATIVE TO APPLY AI TECHNOLOGY ACROSS THE TCM SUPPLY CHAIN
January 16, 2026
·
3 min read
Press Releases
Cycle Pharmaceuticals Completes Acquisition of Applied Therapeutics
February 4, 2026
·
1 min read
Press Releases
Cycle Pharmaceuticals Announces Extension of Applied Therapeutics Tender Offer
January 29, 2026
·
7 min read
Press Releases
Cycle Pharmaceuticals to Acquire Applied Therapeutics
December 12, 2025
·
10 min read
Press Releases
Applied DNA Sciences Closes up to $58 Million Private Placement; Announces Initial BNB Holdings Valued at Over $17 Million
October 23, 2025
·
6 min read
Press Releases
Senseonics Holdings, Inc. to Participate at the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
January 29, 2026
·
1 min read
Press Releases
Applied Therapeutics Announces Corporate Updates
November 21, 2025
·
7 min read
Rare diseases
New Confirmatory Study Hints at ‘Alignment’ Between Applied Therapeutics, FDA for Rare Disease Drug
Applied Therapeutics has yet to confirm whether the study, posted on Clinicaltrials.gov on Thursday, means it has indeed aligned with the FDA on govorestat’s development.
September 29, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Applied DNA Sciences Announces Private Placement of Up To $58 Million To Initiate BNB Treasury Strategy and BNB Native Yield Generation
September 29, 2025
·
14 min read
Press Releases
Dyadic International, Inc. Announces Strategic Rebrand to Dyadic Applied BioSolutions
July 3, 2025
·
5 min read
1 of 74,729
Next
